Effects of Localized Tumor Hyperthermia on Pimonidazole in Mice
Author Information
Author(s): M.I. Walton, N.M. Bleehen, P. Workman
Primary Institution: MRC Clinical Oncology and Radiotherapeutics Unit
Hypothesis
Does localized tumor hyperthermia alter the acute toxicity and pharmacokinetics of pimonidazole?
Conclusion
Localized tumor hyperthermia does not increase the acute toxicity of pimonidazole but significantly reduces its concentrations in tumors.
Supporting Evidence
- LTH had minimal effects on the acute toxicity of pimonidazole.
- Sham treatment increased plasma drug concentrations compared to controls.
- LTH reduced pimonidazole tumor concentrations by 31% compared to sham treatment.
- Brain pimonidazole concentrations were higher in sham-treated mice.
- Plasma clearance was reduced by 26% in sham-treated mice.
Takeaway
Heating tumors a little can help with cancer treatment, but it might make some medicines less effective in the tumors.
Methodology
Mice were treated with pimonidazole and subjected to localized tumor hyperthermia, followed by pharmacokinetic analysis.
Potential Biases
Potential stress-related effects on drug clearance due to treatment protocols.
Limitations
The study was conducted on mice, which may not fully represent human responses.
Participant Demographics
Adult male C3H/He mice, weighing 25-33 g.
Statistical Information
P-Value
p<0.05
Confidence Interval
(720-798)
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website